The University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
NCT Number: NCT07157059
The study was done to learn how doula-enhanced care provided to Black birthing people improved perceived communication and quality care.
Looking for future studies?
Notify Me16 year–50 year
Female
Interventional
Not applicable
Kansas City, Kansas, 66160, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants assigned to the Doula care group received care from the doula pre, during, and post delivery.
Time frame: Study enrollment through 6-weeks postpartum
Assess patient's perception of their quality of communication with their provider using a Likert scale survey (ie. did the patient feel comfortable asking their prenatal provider questions regarding their health, did the patient feel listened to by their provider. Survey scale was 1 to 5 and correlated with agreement or disagreement. Reporting Likert's mean score as surveys were collected at three study timepoints (1. Baseline at study enrollment, 2. Immediate postdelivery, 3. 6-weeks postpartum); higher mean scores indicated more responses in disagreement.
Time frame: Study enrollment through 6-weeks postpartum
Assess patient's perceptions of maternal care using a Likert scale survey (i.e. their physician spending time with the patient talking to them about their labor and delivery expectations) Survey scale was 1 to 5 and correlated with agreement or disagreement. Reporting Likert's mean score as surveys were collected at three study timepoints (1. Baseline at study enrollment, 2. Immediately post-delivery, 3. 6-weeks postpartum); higher mean scores indicated more responses in disagreement.
Time frame: 14-28 weeks GA through delivery
Assess gestational age (GA) at delivery by collecting data from their patient surveys and chart. GA at delivery (write number with one decimal place - "weeks.days". For example, 23 weeks and 4 days = 23.4)
Time frame: 14-28 weeks GA through delivery
Assess preterm <37 weeks births by collecting data from their patient surveys and chart.
Time frame: 14-28 weeks GA through delivery
Assess cesarean sections by collecting data from their patient surveys and chart.
Time frame: 14-28 weeks GA through delivery
Assess gestational hypertension/preeclampsia diagnosis by collecting data from their patient surveys and chart.
Time frame: Birth/delivery
Assess neonatal morbidity by collecting neonatal 5-min Appearance, Pulse, Grimace, Activity, Respiration (APAGAR) score <7. Each of the five criteria can be scored 0-2 with a possible total test score ranging from 0-10 with three subcategories; reassuring: score 7-10, moderately abnormal: 4-6 and low: 0-3. A higher score indicates better neonatal outcomes.
Time frame: Birth through 6-weeks postpartum
Assess neonatal morbidity by collecting neonatal ICU admissions
Time frame: Study enrollment through delivery
Assess antepartum depression using Edinburgh depression screening tool. Edinburgh score scale range is from 0 to 30, a lower score is better as it indicates a participant is less likely to experience depression; the test denotes the following scoring interpretations for total scores: 0-6: minimal depression, 7-13: mild depression, 14-19: moderate depression, 19-30: severe depression. Reporting mean score for the antepartum phase of the study; participants were 14-28 weeks gestation at their study enrollment visit and mean gestational age at delivery for the doula-enhanced group was 37 weeks 5days and 38 weeks 1day for the routine care group.
Time frame: Birth (delivery) through 6-weeks postpartum
Assess postpartum depression using Edinburgh depression screening tool. Edinburgh score scale range is from 0 to 30, a lower score is better as it indicates a participant is less likely to experience depression; the test denotes the following scoring interpretations for total scores: 0-6: minimal depression, 7-13: mild depression, 14-19: moderate depression, 19-30: severe depression. Reporting mean score for the postpartum phase in study participation starting post-delivery during their hospital admission until 6-weeks postpartum.
Time frame: Delivery through hospital discharge
Assess pain management by using the Numerical Rating Scale (NRS) was used for patient's perception of postpartum pain. Zero (0) is the minimum score, which represents the patient reporting no pain, 10 is the maximum score which represents the patient reporting the most intense pain possible. Lower scores are associated with lower postpartum pain perception (better outcome) and higher scores are associated with higher postpartum pain perception (worse outcome) from delivery (mean gestational age at delivery for the doula-enhanced group was 37 weeks 5days and 38 weeks 1day for the routine care group) until hospital discharge.
Time frame: Delivery through hospital discharge
Description: Assess pain management via postpartum total morphine milliequivalent used per the patient's medical chart. Postpartum morphine milliequivalents are reported as the total oral pain medication administered during the postpartum period (this excludes variations in epidural infusion and medications received parenterally). Highest reported mean range pain rating reported by participants on a scale of 0 (no pain) to 10 (excessive pain) from delivery (mean gestational age at delivery for the doula-enhanced group was 37 weeks 5days and 38 weeks 1day for the routine care group) until hospital discharge.
Time frame: Birth
Assess lactation status by asking and recording participants response about initiating lactation and breastfeeding during their labor and delivery admission.
Time frame: Birth through 6-weeks postpartum
Assess lactation status from birth after labor and delivery discharge to 6-week postpartum, by asking and recording participants' responses about their lactation and breastfeed state during their postpartum visits.
University of Kansas Medical Center
Other
Acronym: Doula
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04628598
Pregnancy Related, Prenatal Care
Istanbul, Avcılar, Turkey (Türkiye)
View Trial DetailsNCT06787521
Pregnancy Related
Portland, Oregon, United States
View Trial DetailsNCT06640842
Alzheimer Disease, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT04253626
Anemia, Anemia, Hypochromic
Stanford, California, United States
View Trial Details